The final report of that inquiry found "no evidence of deliberate falsification," as selectively quoted in the Journal article, but did find "a deliberate misrepresentation of procedures." This part of the finding was omitted from Silbergeld's article. The report concluded that "Dr. Needleman was deliberately misleading in the published accounts of the procedures used in the 1979 study." The board unanimously recommended that Dr Needleman submit corrective statements to the journals in which his original studies were published and that he make his complete data set available to any investigator. The Office of Research Integrity reiterated these same findings in its oversight report released in March 1994.
The lead industry never attempted to influence the University of Pittsburgh, the Office of Scientific Integrity, or their inquiries, and to imply otherwise is false.
Other implied accusations in the Silbergeld article, such as that the lead industry tried to stifle the truth about lead exposure and lead poisoning, are equally untrue, as evidenced by a careful reading of her text. For example, she states that the industry association's "greatest triumph" occurred in 1925 when "it overrode opposition to the introduction of tetraethyl lead as a gasoline additive." However, in the previous sentence she states that the association was founded in 1928, a full 3 years after it supposedly achieved its "greatest triumph." This obvious error makes us wonder whether your publication gave any sort of critical examination to the Silbergeld article before publishing it.
We are proud of our industry's outstanding record of encouraging proper use of our product. Lead today is safely used in vehicle batteries, electronic products such as computers and TVs, x-ray shielding, and scores 
The Critics' Ar uments
Dr Ellen Silbergeld portrayed Dr Herbert Needleman as a "courageous man of intellectual integrity" wrongfully accused of misconduct by lead industry representatives, but she ignored the published facts. Although Needleman was found not guilty of scientific misconduct in the legal sense, the investigative bodies (the University of Pittsburgh and the federal Office of Research Integrity) found Needleman's studies scientifically flawed.1'2 Both investigative groups described Needleman's work as involving a "pattem of errors, omissions, contradictions, and incomplete information from the original publication to the present." The University of Pittsburgh found that Needleman had engaged in "deliberate misrepresentation" and "substandard science"; they referred to Needleman's dismissal of critics as lead industry representatives and to his attempts to intimidate his investigators, including the university board itself. The university's report stated that had Needleman accurately described his methodology and subject selection, he "would have risked rejection" of his article by the New England Joumal of Medicine. In addition, the Office of Research Integrity cited misplotted graph points, which were found "difficult to explain as honest error," and uncorrected mistakes in Needleman's original New England Journal ofMedicine manuscript pointed out by a coauthor.
How 
